ArcherDX: Integrated DNA Technologies absorbs ArcherDX tech, Boulder facility in Invitae firesale

BOULDER - A little more than two years after California genetics-testing company Invitae Corp. (NYSE: NVTA) bought ArcherDX Inc., a Boulder developer of genetic assays for cancer patients, for $1.4 billion, some of the company's technology and its local manufacturing, research and development facility has again changed hands - this time for roughly one-thirtieth the ... Continued